Skip to main content
Table 6 · AI in Healthcare · Session 275 Minutes · 15 Seats

From Pilot to Patient

“Where is AI improving patient outcomes and clinical capacity today, and what stops it scaling safely across a health system?”
Roundtable Chair

To be announced

Why This Conversation, Now

AI has rapidly moved beyond speculative proof-of-concepts into boardroom-mandated operational deployments. Across ai in healthcare, the decisive challenge is no longer technological awareness, but systemic integration: deciding where autonomy creates sustainable defensibility, how risk is managed across regulated boundaries, and how capital allocation translates into audited financial return.

This closed-door roundtable gathers fifteen peer leaders to dissect verifiable deployments, structural bottlenecks, and operational trade-offs without marketing posture or vendor slides.

Strategic Scope & Lane Boundary

What This Table Owns

AI in clinical care, hospital operations, life sciences and health insurance. Health-data security sits with AI Security & Governance.

Cross-table boundary: Cross-cutting autonomous agent operating models, workflow orchestration, and group workforce redesign belong to The Agentic Enterprise table.

Discussion Themes
Clinical decision support and imaging
Hospital operations and capacity
Patient experience and virtual care
Health data and interoperability
Clinical validation and regulation
Population health and prevention
Pharma and research
Clinical workforce
Who Will Be in the Room

Strictly senior peer executives curated by Risin Ventures and the roundtable chair:

Health system CIO / CDO
Chief medical information officer / clinical informatics lead
Hospital chief operating or nursing officer
Private hospital group executive
Primary-care operator
Public / population health leader
Ministry of health / regulator (digital health)
Health-data / interoperability lead
Health insurer & Pharma / life-sciences leader
Medical research institution
Digital health / innovation leader
Cloud / enterprise AI provider (health)

Session Specifications

  • 75 Minutes Discussion

    16:30 – 18:00 in dedicated suite.

  • Exactly 15 Seats

    1 chair, up to 2 sponsor leaders, 12 invited guests.

  • Chatham House Rule

    Observations recorded without attribution by designated rapporteur.

  • Plenary & Signals Report

    Findings represented on synthesis stage and published in mid-January 2027.

Doha, 14 December 2026

An invitation-led room of around 110 senior decision-makers, six sponsored roundtables, and high-value stage moments.